Filing Details

Accession Number:
0001140361-20-012852
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-06-01 17:15:21
Reporting Period:
2020-05-28
Accepted Time:
2020-06-01 17:15:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1743881 Bridgebio Pharma Inc. BBIO () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1081714 R Henry Kravis 9 West 57Th Street, Suite 4200
New York NY 10019
No No No No
1081715 R George Roberts 2800 Sand Hill Road, Suite 200
Menlo Park CA 94025
No No No No
1404912 Kkr & Co. Inc. 9 West 57Th Street, Suite 4200
New York NY 10019
No No No No
1472694 Llp Management Kkr 9 West 57Th Street, Suite 4200
New York NY 10019
No No No No
1472698 L.p. Partnership Group Kkr 9 West 57Th Street, Suite 4200
New York NY 10019
No No No No
1743754 Kkr Group Holdings Corp. 9 West 57Th Street, Suite 4200
New York NY 10019
No No No No
1780408 L.p. Disorder Genetic Kkr 9 West 57Th Street, Suite 4200
New York NY 10019
No No No No
1780428 Kkr Genetic Disorder Gp Llc 9 West 57Th Street, Suite 4200
New York, NY 10019
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-05-28 2,389,690 $33.39 34,510,971 No 4 S Indirect See footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnotes
Footnotes
  1. The securities of the Issuer are held by KKR Genetic Disorder L.P. KKR Genetic Disorder GP LLC, as the general partner of KKR Genetic Disorder L.P., KKR Group Partnership L.P., as the sole member of KKR Genetic Disorder GP LLC, KKR Group Holdings Corp., as the general partner of KKR Group Partnership L.P., KKR & Co. Inc., as the sole shareholder of KKR Group Holdings Corp., KKR Management LLP, as the Series I preferred stockholder of KKR & Co. Inc., and Messrs. Henry R. Kravis and George R. Roberts, as the founding partners of KKR Management LLP, may be deemed to be the beneficial owners having shared voting and investment power with respect to the shares described above. Each of Messrs. Kravis and Roberts disclaims beneficial ownership of the shares held by KKR Genetic Disorder L.P.
  2. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Persons are the beneficial owners of any securities reported herein.